Inventor · disambiguated record
Brian Springthorpe
Also filed as: SPRINGTHORPE BRIAN
29 granted patents·25 pending applications·455 citations·filing 1986–2014
97Inventor score
Top patents by PatentIndex Score
54 records- 0193US7250419B2Trisubstituted triazolopyrimidines for use in platelet aggregation inhibitionASTRAZENECA AB·Filed 2005·Granted Jul 31, 2007·16 cites·14 claims
- 0292US6525060B1Triazolo(4,5-d)pyrimidine compoundsASTRAZENECA UK LTD·Filed 1999·Granted Feb 25, 2003·59 cites·14 claims
- 0391US7179922B2Chemical compoundsASTRAZENECA AB·Filed 2005·Granted Feb 20, 2007·16 cites·18 claims
- 0491US6903115B2Bipiperidine compoundsASTRAZENECA AB·Filed 2003·Granted Jun 7, 2005·35 cites·13 claims
- 0590US6525070B2Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonistsASTRAZENECA AB·Filed 2001·Granted Feb 25, 2003·33 cites·13 claims
- 0690US6251910B11,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonistsASTRAZENECA UK LTD·Filed 1998·Granted Jun 26, 2001·55 cites·14 claims
- 0789US6974868B2CompoundsASTRAZENECA AB·Filed 2002·Granted Dec 13, 2005·20 cites·2 claims
- 0887US6903085B1Substituted piperidine compounds useful as modulators of chemokine receptor activityASTRAZENECA AB·Filed 2000·Granted Jun 7, 2005·37 cites·6 claims
- 0985US7238811B2Chemical compoundsASTRAZENECA AB·Filed 2003·Granted Jul 3, 2007·16 cites·5 claims
- 1083US7265227B2Piperidine derivatives useful as modulators of chemokine receptor activityASTRAZENECA AB·Filed 2002·Granted Sep 4, 2007·22 cites·11 claims
- 1181US6713483B1[1,2,3]-triazolo[4,5-d] pyrimidine compoundsASTRAZENECA AB·Filed 2000·Granted Mar 30, 2004·16 cites·20 claims
- 1280US7307090B2Piperidine derivatives useful as modulators of chemokine receptor activityASTRAZENECA AB·Filed 2002·Granted Dec 11, 2007·15 cites·9 claims
- 1380US7238691B2Piperidine derivatives and their use as modulators of chemokine (especially CCR3) activityASTRAZENECA AB·Filed 2002·Granted Jul 3, 2007·14 cites·10 claims
- 1477US7709500B2Chemical compoundsASTRAZENECA AB·Filed 2003·Granted May 4, 2010·11 cites·14 claims
- 1574US6958350B2Chemical compoundsASTRAZENECA AB·Filed 2002·Granted Oct 25, 2005·7 cites·8 claims
- 1673US4922022ASubstituted 3,4-dihydroxy phenylethylamino compoundsFISONS PLC·Filed 1988·Granted May 1, 1990·10 cites·13 claims
- 1772US7517989B2Piperidine derivatives useful as modulators of chemokine receptor activityASTRAZENECA AB·Filed 2003·Granted Apr 14, 2009·5 cites·6 claims
- 1871US2010069408A1Trisubstituted triazolopyrimidines for use in platelet aggregation inhibitionASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1969US7348341B2Chemical compoundsASTRAZENECA AB·Filed 2001·Granted Mar 25, 2008·4 cites·16 claims
- 2068US2008214812A1Trisubstituted triazolopyrimidines for use in platelet aggregation inhibitionASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2168US2015152111A1Trisubstituted triazolopyrimidines for use in platelet aggregation inhibitionASTRAZENECA UK LTD·Filed 2014·Application pending·0 cites
- 2267US7495013B2Chemical compoundsASTRAZENECA AB·Filed 2004·Granted Feb 24, 2009·4 cites·19 claims
- 2366US2014296258A1Trisubstituted triazolopyrimidines for use in platelet aggregation inhibitonASTRAZENECA UK LTD·Filed 2013·Application pending·0 cites
- 2465US7034032B2Cyclopentan-2-ol-1-yl-[1,2,3]triazolo[4,5-D]pyrimidine compoundsASTRAZENECA AB·Filed 2001·Granted Apr 25, 2006·2 cites·16 claims
- 2564US2007265282A1Novel compoundsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2664US2013109702A1Trisubstituted triazolopyrimidines for use in platelet aggregation inhibitionASTRAZENECA AB·Filed 2012·Application pending·0 cites
- 2763US4939147ASubstituted 3,4-dihydroxy phenylethylamino compoundsFISONS PLC·Filed 1989·Granted Jul 3, 1990·6 cites·11 claims
- 2862US6369064B1Triazolo(4,5-d)pyrimidine compoundsASTRAZENECA AB·Filed 1999·Granted Apr 9, 2002·20 cites·9 claims
- 2962US2013072503A1Trisubstituted triazolopyrimidines for use in platelet aggregation inhibitionHARDERN DAVID·Filed 2012·Application pending·0 cites
- 3061US2012165348A1Novel compoundsHARDERN DAVID·Filed 2011·Application pending·0 cites
- 3160US6156756ATriazolo [4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparationASTRAZENECA UK LTD·Filed 1998·Granted Dec 5, 2000·17 cites·12 claims
- 3260US2007179297A1Chemical compoundsASTRAZENECA AB A SWEDEN CORP·Filed 2007·Application pending·0 cites
- 3359US6297232B1Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicamentsASTRAZENECA AB·Filed 1997·Granted Oct 2, 2001·15 cites·14 claims
- 3458US2009069325A1Piperidine Derivatives Useful as Modulators of Chemokine Receptor ActivityASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 3556US2009118513A1Chemical CompoundsASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 3647US2007048215A1Chemical compound and assaySPRINGTHORPE BRIAN·Filed 2004·Application pending·0 cites
- 3746US8314127B2Piperidine derivativesAUSTIN TALBIR·Filed 2006·Granted Nov 20, 2012·0 cites·3 claims
- 3846US2009197914A1Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing ThemCAGE PETER·Filed 2007·Application pending·0 cites
- 3945US2005250792A1Substituted piperidine compounds useful as modulators of chemokine receptor activityTHOM STEPHEN·Filed 2005·Application pending·0 cites
- 4045US2009023733A1Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing ThemCAGE PETER·Filed 2007·Application pending·0 cites
- 4145US2006281726A1Piperidine derivatives for the treatment of chemokine or h1 mediated disease stateLUCKHURST CHRISTOPHER·Filed 2004·Application pending·0 cites
- 4244US2009118288A1N-Benzyl-Morpholine Derivatives as Modulators of the Chemokine ReceptorASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4344US2008275084A1Piperidines for the Treatment of Chemokine Mediated DiseasesASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4444US2008200505A1Piperidines for the Treatment of Chemokine Mediated DiseasesASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4544US2013023562A1Novel piperidine derivativesASTRAZENECA AB·Filed 2012·Application pending·0 cites
- 4644US2006040984A1Novel piperidine derivatives for use in the treatment of chemokine medicated disease statesLUCKHURST CHRISTOPHER·Filed 2003·Application pending·0 cites
- 4743US7482363B2Piperidine derivatives useful as modulators of chemokine receptor activityASTRAZENECA AB·Filed 2003·Granted Jan 27, 2009·0 cites·7 claims
- 4843US2009012125A1Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing ThemCAGE PETER·Filed 2007·Application pending·0 cites
- 4941US2007276141A1Preparation of Pharmaceutical Salts of [1,4] - BipiperidineELSE HOWARD·Filed 2004·Application pending·0 cites
- 5040US7304077B2Chemical compoundsASTRAZENECA AB·Filed 2001·Granted Dec 4, 2007·0 cites·9 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →